Transcat Inc (TRNS) Stock Forecast Oct. 15, 2026
Analysis updated on Oct. 15, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Transcat Inc (TRNS) stock forecast summary
On Oct. 15, 2026, TRNS is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5380 stocks scored that day.
Transcat Inc is a small-cap company with a market capitalization of $771M. It ranks number 7 by market capitalization among the 9 Instruments For Meas & Testing of Electricity & Elec Signals issuers in our coverage with a current forecast. Its Gross Margin of 32.4% is the lowest of the 9 peers that report one.
A per-ticker accuracy statistic for TRNS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, TRNS included.
Follow TRNS freeTRNS price chart and AI forecast
How TRNS ranks among 5380 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Transcat Inc (TRNS) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Instruments For Meas & Testing of Electricity & Elec Signals peers listed below that report each metric.
Valuation & Market
| Metric | TRNS | Rank |
|---|---|---|
| Market Cap | $771M | 7/9 |
| P/E Ratio | 223.73x | 3/7 |
| P/B Ratio | 2.55x | 6/9 |
| EPS | $0.36 | – |
| Book Value/Share | $32.36 | – |
| Revenue/Share | $37.22 | – |
| FCF/Share | $2.71 | – |
Profitability & Margins
| Metric | TRNS | Rank |
|---|---|---|
| ROE | 1.1% | 6/9 |
| ROA | 0.7% | 6/9 |
| ROIC | 2.6% | 5/9 |
| Gross Margin | 32.4% | 9/9 |
| Operating Margin | 3.3% | 5/9 |
| Net Margin | 1.0% | 6/9 |
| EBT Margin | 1.6% | 6/9 |
| Tax Rate | 38.6% | – |
Financial Health
| Metric | TRNS | Rank |
|---|---|---|
| Current Ratio | 2.49x | 5/10 |
| Quick Ratio | 2.11x | 4/10 |
| D/E Ratio | 0.63x | 5/9 |
| Financial Leverage | 1.63x | 5/9 |
| Interest Coverage | 19.7x | 3/9 |
| Working Capital | $57M | 7/10 |
Cash Flow
| Metric | TRNS | Rank |
|---|---|---|
| Operating Cash Flow | $40M | 4/9 |
| Free Cash Flow | $25M | 5/8 |
| Capital Spending | -$15M | 5/8 |
| OCF Growth YoY | 18.9% | 4/6 |
| FCF Growth YoY | 29.6% | 3/6 |
| FCF/Sales | 7.3% | 4/8 |
| CapEx/Sales | 4.2% | 2/8 |
Operational Efficiency
| Metric | TRNS | Rank |
|---|---|---|
| Asset Turnover | 0.71x | 5/8 |
| Receivables Turnover | 5.2x | 5/8 |
| Inventory Turnover | 15.9x | 1/9 |
| Fixed Assets Turnover | 6.0x | 7/8 |
| Days Sales Outstanding | 70 days | 4/8 |
| Days Inventory | 23 days | 9/9 |
| Payables Period | 32 days | 7/7 |
| Cash Conversion Cycle | 61 days | 6/6 |
Income Statement
| Metric | TRNS | Rank |
|---|---|---|
| Total Revenue | $348M | 5/8 |
| Operating Income | $11M | 5/9 |
| Net Income | $3M | 5/9 |
| SG&A Expense | $118M | 4/9 |
| Cost of Goods Sold | $235M | 5/9 |
Dividend & Shareholder Information
| Metric | TRNS | Rank |
|---|---|---|
| Shares Outstanding | 9M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $96M | 19.4% of assets |
| Cash & Short-term Investments | $7M | 1.4% of assets |
| Accounts Receivable | $67M | 13.5% of assets |
| Inventory | $15M | 3.0% of assets |
| Total Liabilities | $190M | 38.5% of assets |
| Short-term Debt | $18M | 3.7% of assets |
TRNS quarterly financials and insider trading
Transcat Inc (TRNS) industry peers
Companies classified under the same SEC industry code as Transcat Inc (Instruments For Meas & Testing of Electricity & Elec Signals): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| TRNS Transcat Inc | ▶ | $771M |
| TER Teradyne, Inc | ▼ | $56.20B |
| VLTO Veralto Corp | ▼ | $24.72B |
| ITRI Itron, Inc. | ▼ | $3.70B |
| AEHR Aehr Test Systems | ▲ | $2.33B |
| ALNT Allient Inc | ▲ | $1.69B |
| FEIM Frequency Electronics Inc | ▲ | $803M |
| INTT Intest Corp | ▲ | $165M |
| DAIO Data I/O Corp | ▲ | $29M |
| STAI Scantech Ai Systems Inc. | ▼ | N/A |
Where TRNS sits on the market map
Transcat Inc (TRNS) stock news
Loading...
Transcat Inc (TRNS) stock forecast FAQ
What is the Transcat Inc (TRNS) stock forecast?
On Oct. 15, 2026, TRNS is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5380 stocks scored that day.
How accurate are Transcat Inc stock predictions?
A per-ticker accuracy statistic for TRNS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Transcat Inc forecasts updated?
Transcat Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 15, 2026.
Which companies are Transcat Inc's industry peers?
10 issuers in our coverage, TRNS included, share the SEC industry code Instruments For Meas & Testing of Electricity & Elec Signals. The largest are: Teradyne, Inc (TER), Veralto Corp (VLTO), Itron, Inc. (ITRI), Aehr Test Systems (AEHR), Allient Inc (ALNT), Frequency Electronics Inc (FEIM).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.